ICRP has established a mentorship programme to engage university students and early-career professionals and scientists as mentees in ICRP Task Groups with the guidance of an ICRP member as mentor.
Mentees may come from educational, governmental, private, or any other organisation. This is a part-time voluntary arrangement, with mentees continuing to work at their home organisation most of the time. There is no fee, but the mentee’s home organisation bears any costs associated with the mentorship.
While mentees are encouraged to engage fully in the work of the Task Group, they are assigned specific roles or tasks, defined in advance. Ideally the mentee will have an opportunity to participate directly in a meeting of the Task Group, and/or the possibility of working with the mentor at their institute. The assignment is for a pre-set period, typically one year with possibility of renewal. During this time, the mentee will be a member of the Task Group.
The mentor, normally a member of the Task Group, is responsible for providing guidance and support to the mentee, including discussing and reviewing the tasks assigned.
At the end of the mentorship period the mentor and the mentee each submit a brief confidential report which will be used to progressively improve the mentorship programme.
Please check back for future opportunities
|Task Group||Mentor||Task(s) / Role||Application Period|
If you are interested in one of the Mentorship Opportunities listed above, please send the following to email@example.com in English and in pdf format:
Receipt of your application will be acknowledged within one week of receiving it.
Candidates will normally be selected shortly after the application deadline shown above. All applicants will be informed of the outcome.
Once selected, details of the mentorship placement will be discussed with the candidate, and a formal letter of invitation will be sent from ICRP to the candidate outlining all the relevant details.
Unless otherwise specified, placements are for one year with possibility of renewal, beginning at the earliest convenience of the mentee and mentor.
|Task Group||Mentee(s)||Mentor||Task(s) / Role||Period|
|Task Group 98 Exposures Resulting from Contaminated Sites from Past Industrial, Military and Nuclear Activities||Corynne McGuire, Scottish Environment Protection Agency||Michael Boyd, TG98 Chair||Review and completion of case studies that will be part of the report, preparation of the report for discussion by the ICRP Main Commission and Committee 4, developing responses to comments and preparation of a revised draft for public consultation.||From 15 September 2019; extended to 31 December 2021|
|Task Group 99 Reference Animals and Plants (RAPs) Monographs||Katherine Raines, UK||David Copplestone, TG99 Chair||Comparing data treatment methodologies and making recommendations for improvement or extension to other datasets; helping update effects data on invertebrates by integrating results from publications released after 2010; contributing to laboratory to field comparisons; and, contributing to the methodology for extrapolation of effects from the individual level to a population of a given species.||From 1 July 2019; extended to 31 December 2021|
|Task Group 105 Considering the Environment when Applying the System of Radiological Protection||Megan Cook, ARPANSA, Australia||Gillian Hirth, TG105 Member||Carry out a review of selected case studies related to the work of the Task Group.||One year starting 18 May 2020, extended to 31 May 2023|
|Task Group 110
Radiological Protection in Veterinary Practice
|Anthony Davila, USA||Nicole Martinez, TG110 Co-Chair||Critical review of relevant peer-reviewed literature, particularly as related to health effects in animals at low doses and dose rates, and how these effects and time of onset compare to human effects, and reviewing modern ethical philosophy and deontology associated with animal health care and welfare.||One year starting 27 April 2020, extended 30 April 2022|
|Task Group 111 Factors Governing the Individual Response of Humans to Ionising Radiation||Stephen Barnard, Public Health England, UK||Nobuyuki Hamada, TG111 Member||Literature review relating to the biology and epidemiology of late-developing tissue reactions, in particular, cataracts, circulatory disease and neurodegenerative disease.||One year starting 1 April 2020; extended to 31 March 2022|
|Task Group 111 Factors Governing the Individual Response of Humans to Ionising Radiation||Julie Leblanc, Canadian Nuclear Safety Commission||Simon Bouffler, TG111 Chair||Literature review relating to the modification of responses to ionisingradiation by sex. There may be an opportunity to extend this to include modification of radiation responses by other factors.||One year starting 1 April 2020; extended to 31 March 2022|
|Task Group 111 Factors Governing the Individual Response of Humans to Ionising Radiation||Weiwei Pei, Soochow University, China||Andrzej Wojcik, TG111 Member||Literature review relating to the modification of responses to ionisingradiation by various life-style factors. There may be an opportunity to extend this to include modification of radiation responses by other factors.||One year starting 7 April 2020; extended to 31 March 2022|
|Task Group 113 Reference Organ and Effective Dose Coefficients for Common Diagnostic X-ray Imaging Examinations||Fang Shijie, University of Science and Technology of China||Nina Petoussi-Henss, TG113 Chair||Monte Carlo calculations with the ICRP age-dependent reference phantoms for diagnostic examinations of the chest, lumbar spine, pelvis, and abdomen. CT examinations might be considered, if the time allows it.||From 1 October 2019; extended to 1 October 2021|
|Task Group 114 Reasonableness and Tolerability in the System of Radiological Protection||Momo Takada, Japan||Thierry Schneider, TG114 Chair||Collaboration on a position paper on a topic identified by the Task Group.||One year starting 1 January 2020; extended to 31 December 2021|
|Task Group 116 Radiological Protection Aspects of Imaging in Radiotherapy||Abdullah Abuhaimed, King Abdulaziz City for Science and Technology, Saudi Arabia||Colin Martin, TG116 Member||Monte Carlo modelling to evaluate radiation doses to patients from imaging that will assist in evaluation of different optimisation strategies, especially relating to cone beam CT. This will include modelling of doses to sets of anatomical phantoms of varying size that may provide information which can be used in advising on adjustments that should be made for individual patients.||One year starting 1 April 2020, extended to 31 March 2023|
|Task Group 116 Radiological Protection Aspects of Imaging in Radiotherapy||Mario Djukelic, Sir Charles Gairdner Hospital, Australia||Tomas Kron, TG116 Member||Prepare notes or literature reviews on specific topics relating to the Task Group.||One year starting 1 April 2020; extended to 31 March 2023|
|Task Group 116 Radiological Protection Aspects of Imaging in Radiotherapy||Sebastien Gros, Loyola University Medical Center, USA||William Small Jr,, TG116 Co-Chair||Develop specific sections of the Task Group document, and help review other sections.||One year starting 1 April 2020, extended to 31 March 2023|
|Task Group 116 Radiological Protection Aspects of Imaging in Radiotherapy||Abdel-Hai Benali, Algeria
Maria Cristine Plazas d'Leon, Columbia
Yiannis Roussakis, Cyprus and Greece
Hossam Ragab Shaaban, Egypt
|Colin Martin, TG116 Chair||As part of a team lead by Colin Martin, Jenia Vassileva, and Tim Wood, assist in the organisation of an international survey of imaging in radiotherapy. Establish contacts with radiotherapy departments in your country, distribute questionnaires, and carry out initial analysis of the data collected. Provide observations and insights into the way imaging is used and potential approaches to improving optimisation of radiological protection in your region.||One year starting 1 May 2020; extended to 30 April 2022|